• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The development of gene therapy for breast cancer using targeted measles virus vectors

Research Project

Project/Area Number 25430152
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Tumor therapeutics
Research InstitutionKyushu University

Principal Investigator

Matsumura Yumiko  九州大学, 生体防御医学研究所, 研究員 (90594911)

Co-Investigator(Renkei-kenkyūsha) NAKAMURA Takafumi  鳥取大学, 医学学研究科, 准教授 (70432911)
TANIGUCHI Hiroaki  東京大学, 医科学研究所, 特任准教授 (90563289)
Project Period (FY) 2013-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords遺伝子治療 / 癌治療 / 分子標的薬 / 癌幹細胞 / ウイルスベクター
Outline of Final Research Achievements

Breast cancer contains a heterogeneous population of cells with a small percentage that have increased resistance to conventional therapies and are capable of establishing metastasis. We found that the expression of novel two genes identified the breast cancer stem cells in human cell lines. We engineered the new measles-based viral vectors which have several advantages in targeted gene therapy. In this study, we proved the potential antitumor capability of the engineered vaccine strain of the measles virus against human breast cancer.

Report

(4 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2014 Research-status Report
  • 2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi